Details for 2018701296

Up to date per 01.04.2026

Actions

Title / Product Name

JAK1-SELEKTIVE INHIBITOREN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018701296

EP Publication Number

3571192

E-Number

1534620

Language

PCT Number

EP18051038

Publication Date

27.11.2019 A

30.11.2022 B1

Registration Date

30.11.2022

AT Publication Date

15.12.2022

Application Date

16.01.2018

Registration Number

Priorities

17.01.2017

201762447057 P

IPC

C07D 403/04 20060101AFI20180727BHEP

Maximum Duration of Protection

16.01.2038

Owner

Astrazeneca AB 151 85 SödertäljeSE

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

NILSSON, Karl, MagnusAstraZeneca 431 83 MölndalSE

ÅSTRAND, Annika, Birgitta, MargaretaAstraZeneca 431 83 MölndalSE

BERGGREN, Anna, Ingrid, KristinaAstraZeneca 431 83 MölndalSE

JOHANSSON, Johan, R.AstraZeneca 431 83 MölndalSE

LEPISTÖ, Matti, JuhaniAstraZeneca 431 83 MölndalSE

KAWATKAR, Sameer, PralhadAstrazeneca Pharmaceuticals LP 1800 Concord Pike Wilmington, DE 19803US

SU, QibinAstrazeneca Pharmaceuticals LP 1800 Concord Pike Wilmington, DE 19803US

KETTLE, Jason, Grant1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AAGB

Information about Fees